Top 5 Stock Picks of John Zaro’s Bourgeon Capital

1. Merck & Co., Inc. (NYSE:MRK)

Bourgeon Capital’s Stake Value: $15,305,000

Percentage of Bourgeon Capital’s 13F Portfolio: 4.04%

Number of Hedge Fund Holders: 79

Merck & Co., Inc. (NYSE:MRK) is a biopharmaceutical company with a focus on delivering solutions for oncology, vaccines, infectious diseases, Cardio-metabolic disorders, and Discovery & development. Its product pipeline comprises 83 programs in Phase 2, 30 programs in Phase 3, and 3 programs Under Review, including a COVID19 vaccines.

Bourgeon Capital holds 167,874 shares of Merck & Co., Inc. (NYSE:MRK), accounting for 4.04% of the hedge fund’s 13F portfolio and ranking the stock on #1 on the list of top 5 and 10 stock picks of John Zaro’s Bourgeon Capital. Bourgeon Capital’s stake increased by 1% in Q2 2022, compared to the previous quarter.

In July, Merck & Co., Inc. (NYSE:MRK) released the financial results for Q2 2022. Its revenue increased 28% y-o-y to $14.6 billion, while it reported a net income of $3.9 billion, for three months ended June 30, 2022. It reported a normalized EPS of $1.87, beating analyst consensus by $0.16.

Following the earnings release, Barclays analyst Carter Gould raised the price target on Merck & Co., Inc. (NYSE:MRK) shares to $101 from $97, maintaining an ‘Overweight’ rating for the stock.

Merck & Co., Inc. (NYSE:MRK) ranks high on the list of companies displaying significant interest from hedge funds tracked by Insider Monkey. As of Q2 2022, 79 hedge funds tracked by Insider Monkey held a stake in Merck & Co., Inc. (NYSE:MRK), valued at a total of $6.1 billion.

You can also take a look at the 5 Best Stocks to Invest Your $1000 According to Reddit and Here’s Why Arch Capital Invested in Alphabet (GOOG).

Follow Insider Monkey on Twitter